Wutah pendapatan taun lumaku: NLS Pharmaceutics AG (NLSP)

Logo grafis NLS Pharmaceutics (NLSP)

Can NLS Pharmaceutics AG (NLSP) meet the high demand for narcolepsy treatment? NLS Pharmaceutics AG (NLSP) is integrating ESG principles and bioethics into the development of insomnia treatments, as evidenced by the year-over-year sales trend over the last 12 months on the GURU.Markets chart, where the latest value is recorded as 0.00. This is further supported by the diversification of research and development in the fields of ADHD and cognitive disorders.

NLS Pharmaceutics (NLSP): Wutah pendapatan YoY sajrone 12 wulan kepungkur saka 11.02.2024 nganti 20.02.2024

Ringkesan rincian data analitis NLS Pharma (NLSP)

- rega saham lan target rega konsensus:
- indikator kapitalisasi bursa perusahaan:
Analisis kabeh metrik perusahaan:NLSP NLS Pharmaceutics Ltd.
Barang unggulan NLS Pharmaceutics Ltd.

This indicator captures the percentage change in revenue over the last 12 months relative to the preceding year, allowing for an assessment of the actual cash flow stability. By analyzing the year-over-year commercial revenue dynamics over a rolling year, an investor can determine the effectiveness of the current NLS Pharmaceutics AG (NLSP) strategy to expand its neuro-drug portfolio through potential M&A transactions or the integration of new technological teams.